First of six FREE webinars on making well-informed prostate cancer decisions | THE "NEW" PROSTATE CANCER INFOLINK

First of six FREE webinars on making well-informed prostate cancer decisions | THE "NEW" PROSTATE CANCER INFOLINK

prostatecancerinfolink.net

First of six FREE webinars on making well-informed prostate cancer decisions

3-4 minutes

Posted on May 14, 2021 by Sitemaster

On Wednesday, May 26, the Cancer Support Community together with Prostate Cancer International will be holding the first of a series of six FREE educational webinars for patients and family members.

As we have become better at identifying the risk level of prostate cancer at the several major stages in what can be a long prostate cancer journey, it has become more and more important that patients learn how to work with their doctors to assess the risks associated with their disease before they take decisions about any immediate or later form of treatment.

This series of educational webinars will therefore focus on the evolving methods for the diagnosis and work-up of patients that will allow them the best understanding of how they might respond to the evolving spectrum of management options that might be appropriate in their individual cases.

The first of these webinars will be on

Diagnosis and Work-up of Men with Relatively Low-Risk Prostate Cancer:
What You Need to Know

The speaker will be M. Minhaj Siddiqui, MD, a urologic oncologist specializing in the management of prostate cancer at the University of Maryland, Baltimore, MD.

Dr. Siddiqui will give an opening presentation for about 25 minutes, starting at 7:00 p.m. Eastern (4:00 p.m. Pacific) on the evening of May 26. There will then be opportunities for attendees to pose questions to Dr. Siddiqui for the following hour, with the meeting ending at about 8:30 p.m. Eastern (5:30 p.m. Pacific).

You will be able to take advantage of this educational webinar in three ways:

This webinar will be particularly useful to cancer and prostate cancer support group leaders, patients diagnosed with or at risk for localized forms of prostate cancer, and their families. Dr. Siddiqui will address all of the issues and evolving tests that help to define patients with lower-risk forms of prostate cancer, including those who are or are not potentially good candidates for initial management on active surveillance (AS) as opposed to needing immediate treatment for their cancer.

Further webinars will be held on the last Wednesday of June through October this year. The second such webinar with address Diagnosis and Work-up of Men with Relatively High-Risk Prostate Cancer: What You Need to Know, and the speaker will be Eric Klein, MD, of the Cleveland Clinic, Cleveland, OH.

We wish to emphasize that these webinars are not supported by any commercial sponsor.

Filed under: Uncategorized |

 

Comments

Post a Comment

Popular posts from this blog

A 10-Second Steam Blast: The New Weapon Against Prostate Cancer?

Image
Vanquish® Water Vapor Ablation System, Francis Medical Steams Out Prostate Cancer The Vanquish® Water Vapor Ablation System, developed by Francis Medical, Inc. , represents an innovative approach to treating prostate cancer using water vapor (steam) to ablate cancerous tissue. This minimally invasive technique aims to target and destroy prostate cancer cells while minimizing damage to surrounding healthy tissue, potentially reducing common side effects associated with traditional treatments like surgery and radiation, Mechanism of Action:  The Vanquish system utilizes the thermal energy stored in sterile water vapor to ablate cancerous prostate tissue. During the procedure, a catheter is inserted through the urethra into the prostate, delivering water vapor directly to the targeted tissue. As the vapor condenses back into liquid, it releases stored thermal energy, effectively destroying the cancerous cells. This method is designed to respect the prostate's natural boundaries, ...
Read more

Researchers develop low-cost device that detects cancer in an hour | ScienceDaily

Image
Summary Sanjay S. Timilsina , currently Lead Scientist, StataDx, a spinoff from Wyss Institute, former Postdoctoral Fellow at Harvard Medical School and the Wyss Institute at Harvard University, PhD from UTEP Department of Chemistry & Biochemistry, and XiuJun Li full Professor in the Department of Chemistry and Biochemistry and of Forensic Science, & Environmental Science and Engineering, at the University of Texas at El Paso (UTEP) have developed a new portable device for cancer detection that offers several advantages over traditional methods: Key Features: - Low cost (a few dollars per device, <8 cents per assay) - Provides results in about 1 hour (vs. 12-16 hours for traditional methods) - Approximately 10 times more sensitive than traditional methods - Portable and doesn't require specialized instruments - Can detect both CEA colorectal and PSA prostate cancer biomarkers - Uses a "paper-in-polymer-pond" structure to analyze blood samples How it works: - U...
Read more

Cancer patients and doctors team up to change how cancer drugs are tested | Fox News

Cancer patients and doctors team up to change how cancer drugs are tested | Fox News foxnews.com Associated Press For cancer patients, the harsh side effects of powerful drugs have long been the trade-off for living longer. Now, patients and doctors are questioning whether all that suffering is necessary. They’ve ignited a movement to radically change how new cancer drugs are tested, with the U.S. Food and Drug Administration urging drugmakers to do a better job at finding the lowest effective dose, even if it takes more time. Advances in treatment mean millions of people are surviving for years with incurable cancers. Jill Feldman, 54, of Deerfield, Illinois, has lived 15 years with lung cancer , thanks to that progress. Her parents both died of lung cancer months after their diagnoses. But her cancer drug causes joint pain, fatigue and mouth sores that m...
Read more